Lipocine (LPCN) Short Interest Ratio & Short Volume $3.30 0.00 (0.00%) Closing price 06/11/2025 03:59 PM EasternExtended Trading$3.32 +0.03 (+0.76%) As of 06/11/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lipocine Short Interest DataLipocine (LPCN) has a short interest of 96,300 shares, representing 1.86% of the float (the number of shares available for trading by the public). This marks a 13.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 37,379 shares to cover all short positions.Current Short Interest96,300 sharesPrevious Short Interest85,000 sharesChange Vs. Previous Month+13.29%Dollar Volume Sold Short$323.57 thousandShort Interest Ratio2.4 Days to CoverLast Record DateMay 31, 2025Outstanding Shares5,350,000 sharesFloat Size5,190,000 sharesShort Percent of Float1.86%Today's Trading Volume58,349 sharesAverage Trading Volume37,379 sharesToday's Volume Vs. Average156% Short Selling Lipocine? Sign up to receive the latest short interest report for Lipocine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLPCN Short Interest Over TimeLPCN Days to Cover Over TimeLPCN Percentage of Float Shorted Over Time Lipocine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202596,300 shares $323.57 thousand +13.3%1.9%2.4 $3.36 5/15/202585,000 shares $317.05 thousand +20.4%1.6%2.9 $3.73 4/30/202570,600 shares $233.69 thousand -1.8%1.4%4.4 $3.31 4/15/202571,900 shares $219.30 thousand -5.9%1.4%3.8 $3.05 3/31/202576,400 shares $242.95 thousand -7.7%1.5%3.4 $3.18 3/15/202582,800 shares $277.38 thousand +8.7%1.6%3.1 $3.35 2/28/202576,200 shares $233.17 thousand +1.9%1.5%2.6 $3.06 2/15/202574,800 shares $271.52 thousand -3.7%1.4%2.4 $3.63 1/31/202577,700 shares $335.66 thousand +108.9%1.5%2.3 $4.32 1/15/202537,200 shares $171.86 thousand -23.3%0.7%1.2 $4.62 Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 12/31/202448,500 shares $236.68 thousand -21.0%0.9%1.6 $4.88 12/15/202461,400 shares $308.23 thousand -0.8%1.2%2.2 $5.02 11/30/202461,900 shares $281.03 thousand +3.0%1.2%1.9 $4.54 11/15/202460,100 shares $293.89 thousand -20.1%1.2%2 $4.89 10/31/202475,200 shares $416.61 thousand -30.1%1.5%2.4 $5.54 10/15/2024107,500 shares $546.10 thousand -3.0%2.1%3.5 $5.08 9/30/2024110,800 shares $497.49 thousand -20.2%2.1%3.3 $4.49 9/15/2024138,800 shares $639.87 thousand +3.3%2.7%3.8 $4.61 8/31/2024134,400 shares $493.25 thousand -5.0%2.6%2.9 $3.67 8/15/2024141,400 shares $517.52 thousand +21.8%2.7%2.9 $3.66 7/31/2024116,100 shares $604.88 thousand -2.3%2.2%2.3 $5.21 7/15/2024118,800 shares $848.23 thousand -11.1%2.3%2.4 $7.14 6/30/2024133,700 shares $1.10 million -14.1%2.6%1.6 $8.24 6/15/2024155,600 shares $1.48 million -0.4%3.0%1.8 $9.49 5/31/2024156,200 shares $1.08 million -2.9%3.0%2.2 $6.92 5/15/2024160,800 shares $903.70 thousand -11.2%3.1%2.4 $5.62 4/30/2024181,000 shares $836.22 thousand -35.0%3.5%2.8 $4.62 4/15/2024278,400 shares $1.49 million +155.7%5.4%4.5 $5.36 3/31/2024108,900 shares $566.28 thousand -11.9%2.1%3.6 $5.20 3/15/2024123,600 shares $568.56 thousand +11.6%2.4%4.1 $4.60 2/29/2024110,800 shares $422.15 thousand -15.4%2.1%4.3 $3.81 2/15/2024131,000 shares $525.31 thousand -8.8%2.5%5.2 $4.01 1/31/2024143,600 shares $560.04 thousand +31.5%2.8%5.2 $3.90 1/15/2024109,200 shares $378.92 thousand -2.1%2.1%4 $3.47 12/31/2023111,500 shares $311.09 thousand -7.2%2.2%6.4 $2.79 12/15/2023120,100 shares $325.47 thousand -8.7%2.3%7.2 $2.71 11/30/2023131,600 shares $317.16 thousand -14.6%2.6%8.2 $2.41 11/15/2023154,100 shares $420.69 thousand +18.5%3.0%7.8 $2.73 10/31/2023130,000 shares $331.50 thousand -5.6%2.5%6.2 $2.55 10/15/2023137,700 shares $388.31 thousand -8.0%2.7%0.8 $2.82Trump set to Boost Social Security Checks by 400%? (Ad)If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...Click here to see the details because the stakes couldn't be any higher. 9/30/2023149,700 shares $446.11 thousand +14.6%2.9%0.9 $2.98 9/15/2023130,600 shares $475.38 thousand +52.0%2.5%0.8 $3.64 8/31/202385,900 shares $339.31 thousand -12.3%1.7%0.5 $3.95 8/15/202397,900 shares $489.50 thousand -66.9%1.9%0.6 $5.00 7/31/2023296,100 shares $1.47 million +361.2%5.9%1.7 $4.97 7/15/202364,200 shares $277.34 thousand -22.0%1.3%2.5 $4.32 6/30/202382,300 shares $414.79 thousand +2.2%1.6%3.1 $5.04 6/15/202380,500 shares $412.97 thousand -25.8%1.6%3.1 $5.13 5/31/2023108,500 shares $502.36 thousand +35.5%2.1%3.9 $4.63 5/15/202380,100 shares $343.63 thousand +32.0%1.6%3.1 $4.29 4/30/20231,030,000 shares $267.80 thousand -7.2%1.2%5.3 $0.26 4/15/20231,110,000 shares $316.68 thousand -4.3%1.3%6.4 $0.29 3/31/20231,160,000 shares $369.00 thousand -7.9%1.4%6.7 $0.32 3/15/20231,260,000 shares $389.21 thousand -2.3%1.5%7.3 $0.31 2/28/20231,290,000 shares $582.18 thousand -6.5%1.5%10.7 $0.45 2/15/20231,380,000 shares $707.94 thousand -0.7%1.6%11.7 $0.51 1/31/20231,390,000 shares $736.70 thousand -2.8%1.6%10.3 $0.53 1/15/20231,430,000 shares $795.37 thousand -3.4%1.7%10 $0.56 12/30/20221,480,000 shares $588.74 thousand -1.3%1.7%11.1 $0.40 12/15/20221,500,000 shares $662.10 thousand -7.4%1.7%9.2 $0.44 11/30/20221,620,000 shares $729.16 thousand +3.9%1.9%8.7 $0.45 11/15/20221,560,000 shares $646.00 thousand -3.1%1.8%7.8 $0.41 10/31/20221,610,000 shares $658.49 thousand -2.4%1.9%6.6 $0.41 10/15/20221,650,000 shares $742.50 thousand No Change1.9%6.5 $0.45 9/30/20221,650,000 shares $742.50 thousand -13.6%1.9%6.5 $0.45 9/15/20221,910,000 shares $1.11 million +4.4%2.2%8 $0.58 8/31/20221,830,000 shares $1.06 million -5.7%2.1%8.2 $0.58 8/15/20221,940,000 shares $1.37 million -12.2%2.3%8.7 $0.70 7/31/20222,210,000 shares $1.67 million -1.8%N/A10.7 $0.75 7/15/20222,250,000 shares $1.78 million -6.3%N/A8.8 $0.79 6/30/20222,400,000 shares $1.92 million +2.6%N/A7.1 $0.80 6/15/20222,340,000 shares $1.88 million -2.5%N/A4 $0.80 5/31/20222,400,000 shares $1.95 million +16.5%2.8%3.3 $0.81 5/15/20222,060,000 shares $1.60 million -3.7%2.4%2.5 $0.78 4/30/20222,140,000 shares $1.89 million -2.3%2.5%2.5 $0.88 4/15/20222,190,000 shares $2.32 million -8.4%2.6%2.5 $1.06 3/31/20222,390,000 shares $3.27 million -9.5%2.8%2.9 $1.37 3/15/20222,640,000 shares $3.85 million -2.6%3.1%3.9 $1.46 2/28/20222,710,000 shares $3.33 million -1.5%3.2%4.8 $1.23 2/15/20222,750,000 shares $3.19 million -6.5%3.2%5.5 $1.16 1/31/20222,940,000 shares $3.00 million -12.5%3.4%5.6 $1.02 1/15/20223,360,000 shares $3.35 million -6.7%3.9%5.6 $1.00 12/31/20213,600,000 shares $3.57 million -2.4%4.2%6 $0.99 12/15/20213,690,000 shares $3.99 million -7.1%4.3%6.5 $1.08 11/30/20213,970,000 shares $4.37 million -4.6%4.6%6.4 $1.10 11/15/20214,160,000 shares $4.99 million +6.1%4.8%5.2 $1.20 10/29/20213,920,000 shares $4.08 million +2.1%4.6%4.7 $1.04 10/15/20213,840,000 shares $4.34 million -1.5%4.5%4.7 $1.13 9/30/20213,900,000 shares $4.25 million +3.7%4.5%4.4 $1.09 9/15/20213,760,000 shares $4.32 million +0.8%4.4%3.9 $1.15Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 8/31/20213,730,000 shares $4.89 million +0.8%4.3%3.7 $1.31 8/13/20213,700,000 shares $5.37 million +5.4%4.3%3.9 $1.45 7/30/20213,510,000 shares $4.63 million +0.3%4.1%3.3 $1.32 7/15/20213,500,000 shares $4.45 million +10.1%4.1%3.3 $1.27 6/30/20213,180,000 shares $4.45 million +7.1%3.7%3.1 $1.40 6/15/20212,970,000 shares $3.92 million +10.4%3.5%2.6 $1.32 5/28/20212,690,000 shares $3.28 million -14.1%3.1%1.3 $1.22 5/14/20213,130,000 shares $3.91 million -1.6%N/A1.3 $1.25 4/30/20213,180,000 shares $4.55 million -9.1%N/A1.1 $1.43 4/15/20213,500,000 shares $5.15 million -14.4%N/A0.8 $1.47 3/31/20214,090,000 shares $5.89 million -2.2%N/A0.8 $1.44 3/15/20214,180,000 shares $6.94 million +5.6%N/A0.8 $1.66 2/26/20213,960,000 shares $6.02 million -16.5%N/A0.8 $1.52 2/12/20214,740,000 shares $9.53 million -7.6%N/A1 $2.01 1/29/20215,130,000 shares $9.29 million +17.1%N/A1.2 $1.81 1/15/20214,380,000 shares $7.23 million -1.1%N/A1.2 $1.65 12/31/20204,430,000 shares $5.80 million -2.0%N/A1.9 $1.31 12/15/20204,520,000 shares $6.06 million +15.6%N/A2.3 $1.34 11/30/20203,910,000 shares $6.22 million -2.0%N/A2.3 $1.59 11/15/20203,990,000 shares $5.79 million -1.0%N/A1.7 $1.45 10/30/20204,030,000 shares $5.08 million -6.7%N/A1.4 $1.26 10/15/20204,320,000 shares $6.22 million +1.2%N/A1.1 $1.44 9/30/20204,270,000 shares $6.02 million +31.0%N/A0 $1.41 9/15/20203,260,000 shares $4.73 million -26.9%N/A0.8 $1.45 8/31/20204,460,000 shares $6.60 million +72.9%N/A1.1 $1.48 8/14/20202,580,000 shares $5.52 million +49.1%N/A0.8 $2.14 7/31/20201,730,000 shares $2.66 million +117.4%N/A0.7 $1.54 7/15/2020795,700 shares $978.71 thousand -22.0%N/A0.4 $1.23 6/30/20201,020,000 shares $1.29 million -84.6%N/A0.7 $1.26 6/15/20206,630,000 shares $5.97 million -0.5%N/A5.1 $0.90 LPCN Short Interest - Frequently Asked Questions What is Lipocine's current short interest? Short interest is the volume of Lipocine shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 96,300 shares of LPCN short. 1.86% of Lipocine's shares are currently sold short. Learn More on Lipocine's current short interest. What is a good short interest ratio for Lipocine? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPCN shares currently have a short interest ratio of 2.0. Learn More on Lipocine's short interest ratio. What is a good short interest percentage for Lipocine? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.86% of Lipocine's floating shares are currently sold short. Is Lipocine's short interest increasing or decreasing? Lipocine saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 96,300 shares, an increase of 13.3% from the previous total of 85,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lipocine's float size? Lipocine currently has issued a total of 5,350,000 shares. Some of Lipocine's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lipocine currently has a public float of 5,190,000 shares. How does Lipocine's short interest compare to its competitors? 1.86% of Lipocine's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lipocine: Vistagen Therapeutics, Inc. (2.04%), Surrozen, Inc. (0.94%), Skye Bioscience, Inc. (17.41%), MediciNova, Inc. (0.36%), Zura Bio Limited (7.97%), BeyondSpring Inc. (6.28%), Immuneering Co. (3.56%), Immunic, Inc. (4.86%), ZIVO Bioscience, Inc. (1.78%), Exicure, Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Lipocine stock? Short selling LPCN is an investing strategy that aims to generate trading profit from Lipocine as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lipocine? A short squeeze for Lipocine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LPCN, which in turn drives the price of the stock up even further. How often is Lipocine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPCN, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Vistagen Therapeutics Short Interest Surrozen Short Interest Skye Bioscience Short Interest MediciNova Short Interest Zura Bio Short Interest BeyondSpring Short Interest Immuneering Short Interest Immunic Short Interest ZIVO Bioscience Short Interest Exicure Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LPCN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
